2-Benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine: A novel class of antitumor agents

International Journal of Cancer

Volumn 94, Issue 1, 2001, Pages 89-96

  Easmon, Johnny ^a   Puerstinger, Gerhard ^a   Roth, Thomas ^b   Fiebig, Heinz Herbert ^b   Jenny, Marcel ^c   Jaeger, Walter ^d   Heinisch, Gottfried ^a   Hofmann, Johann ^a,e  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b CHARLES RIVER LABORATORIES   (United States)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

^e Institute of Biochemistry   (Austria)

Author keywords

Antitumor agents; Benzimidazolyl hydrazones; Benzoxazolyl hydrazones; Colon cancer

Indexed keywords

2 ACETYLPYRAZINE BENZOTHIAZOL 2 YLHYDRAZONE; 2 ACETYLPYRIDINE; 2 ACETYLPYRIDINE 1 METHYLBENZOIMIDAZOL 2 YLHYDRAZONE; 2 ACETYLPYRIDINE BENZOIMIDAZOL 2 YLHYDRAZONE; 2 ACETYLPYRIDINE BENZOXAZOL 2 YLHYDRAZONE; 2 BENZIMIDAZOLYL HYDRAZONE DERIVATIVE; 2 BENZOXAZOLYL HYDRAZONE DERIVATIVE; 3 ACETYLISOQUINOLINE BENZOXAZOL 2 YLHYDRAZONE; ANTINEOPLASTIC AGENT; HYDRAZONE DERIVATIVE; HYDROXYUREA; PYRIDINE DERIVATIVE; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DRUG METABOLISM; DRUG SYNTHESIS; ENZYME INHIBITION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; COLONIC NEOPLASMS; HUMANS; HYDRAZONES; KB CELLS; MALE; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL;

EID: 0035480045     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1427     Document Type: Article

References (27)

1. Cancer drug discovery and development
2. Cancer of the colon
3. Busulfan versus hydroxyurea in long term therapy of chronic myelogenous leukemia
4. Chemotherapy of advanced colorectal carcinoma: Fluorouracil alone vs two drug combinations using fluorouracil, hydroxyurea, semustine, decarbazine, razoxane, and mitomycin
5. The chemistry and biological activity of α-(N)-heterocyclic carboxaldehyde thiosemicarbazones
6. Chemical and biological properties of cytotoxic α-(N)-heterocyclic carboxaldehyde thiosemicarbazones
7. Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine hydrazone
8. Clinical trial of 5-hydroxypicolinaldehyde thiosemicarbazone (5-HP; NSC-107392), with special reference to its iron-chelating properties
9. Development of inhibitors of mycobacterial ribonucleotide reductase
10. Thiazolyl and benzothiazolyl hydrazones derived from α-(N) acetylpyridines and diazines: Synthesis, antiproliferative activity and CoMFA studies
11. Synthesis, spectral studies and anti-inflammatory activity of some new 2-aryloxybenzimidazoles
12. Antituberculous compounds, III. Benzothiazole and benzoxazole derivatives
13. Benzazoles 2-Hydrazino- and 2-azidobenzimidazoles
14. Pyridazines 47, The configuration of novel thiosemicarbazone derivatives of pyridazinecarbaldehydes and alkyl pyridazinyl ketones
15. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
16. Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine
17. New colorimetric cytotoxicity assay for anticancer-drug screening
18. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
19. Primary bioassay of human tumor stem cells
20. 2,2′-bipyridyl-6 carbothioamide and its ferrous complex: Their in vitro antitumoral activity related to inhibition of ribonucleotide reductase R2 subunit
21. A rapid single step staining technique for DNA analysis by flow microfluorimetry
22. Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
23. Azinyl and diazinyl hydrazones derived from aryl N-heteroaryl ketones: Synthesis and antiproliferative activity
24. Correlation of drug response in patients and in the clonogenic assay with solid human tumor xenografts
25. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage
26. An information-intensive approach to the molecular pharmacology of cancer